Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:40 PM
Ignite Modification Date:
2025-12-24 @ 9:40 PM
NCT ID:
NCT01238432
Eligibility Criteria:
Inclusion Criteria, inpatient asthmatics:
* Admission to study institution with a primary admission diagnosis of asthma exacerbation
* Age between 4 and 18 years
Exclusion Criteria, inpatient asthmatics:
\- Pre-existing chronic disease (other than asthma), including: i. bronchopulmonary dysplasia ii. bronchomalacia iii. tracheomalacia iv. laryngomalacia v. vocal cord dysfunction vi. chronic restrictive lung disease vii. recurrent aspiration pneumonia viii. impaired mucous clearance ix. congenital heart disease x. pulmonary hypertension
Inclusion Criteria, outpatient asthmatics:
* Diagnosis of asthma
* Age between 4 and 18 years
Exclusion Criteria, outpatient asthmatics:
* Previous admission to the hospital for a near fatal asthma exacerbation
* Pre-existing chronic disease (other than asthma) including i. bronchopulmonary dysplasia ii. bronchomalacia iii. tracheomalacia iv. laryngomalacia v. vocal cord dysfunction vi. chronic restrictive lung disease vii. recurrent aspiration pneumonia viii. impaired mucous clearance ix. congenital heart disease x. pulmonary hypertension
Inclusion Criteria, healthy controls:
\- Age between 4 and 18 years
Exclusion Criteria, healthy controls:
\- Pre-existing chronic disease including: i. asthma ii. bronchopulmonary dysplasia iii. bronchomalacia iv. tracheomalacia v. laryngomalacia vi. vocal cord dysfunction vii. chronic restrictive lung disease viii. recurrent aspiration pneumonia ix. impaired mucous clearance x. congenital heart disease xi. pulmonary hypertension
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
4 Years
Maximum Age:
18 Years
Study:
NCT01238432
Study Brief:
Protocol Section:
NCT01238432